BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7885541)

  • 1. Failure of early dextromethorphan and sodium benzoate therapy in an infant with nonketotic hyperglycinemia.
    Zammarchi E; Donati MA; Ciani F; Pasquini E; Pela I; Fiorini P
    Neuropediatrics; 1994 Oct; 25(5):274-6. PubMed ID: 7885541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of low-dose dextromethorphan in the treatment of nonketotic hyperglycinemia.
    Alemzadeh R; Gammeltoft K; Matteson K
    Pediatrics; 1996 Jun; 97(6 Pt 1):924-6. PubMed ID: 8657542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term use of high-dose benzoate and dextromethorphan for the treatment of nonketotic hyperglycinemia.
    Hamosh A; Maher JF; Bellus GA; Rasmussen SA; Johnston MV
    J Pediatr; 1998 Apr; 132(4):709-13. PubMed ID: 9580775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dextromethorphan and high-dose benzoate therapy for nonketotic hyperglycinemia in an infant.
    Hamosh A; McDonald JW; Valle D; Francomano CA; Niedermeyer E; Johnston MV
    J Pediatr; 1992 Jul; 121(1):131-5. PubMed ID: 1385627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of strychnine treatment during the neonatal period in three Finnish children with nonketotic hyperglycinemia.
    von Wendt L; Similä S; Saukkonen AL; Koivisto M
    Pediatrics; 1980 Jun; 65(6):1166-9. PubMed ID: 7375243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonketotic hyperglycinemia in a newborn infant.
    Tekinalp G; Coşkun T; Oran O; Ozalp I; Figen G; Ergin H
    Turk J Pediatr; 1995; 37(1):57-60. PubMed ID: 7732609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early treatment of severe infantile glycine encephalopathy (nonketotic hyperglycinemia) with strychnine and sodium benzoate.
    Melançon SB; Dallaire L; Vincelette P; Potier M; Geoffroy G
    Prog Clin Biol Res; 1979; 34():217-29. PubMed ID: 531053
    [No Abstract]   [Full Text] [Related]  

  • 8. Benzoate therapy and carnitine deficiency in non-ketotic hyperglycinemia.
    Van Hove JL; Kishnani P; Muenzer J; Wenstrup RJ; Summar ML; Brummond MR; Lachiewicz AM; Millington DS; Kahler SG
    Am J Med Genet; 1995 Dec; 59(4):444-53. PubMed ID: 8585564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical progress of neonatal non-ketotic hyperglycinemia under treatment].
    García-Pérez A; Martínez-Granero MA; Martín-Ancel AM; Bonet-Serra B; García-Muñoz MJ; García-Segura JM; Viaño J; Lama-More RA
    Rev Neurol; 2004 Oct 16-31; 39(8):727-30. PubMed ID: 15514900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early myoclonic encephalopathy and nonketotic hyperglycinemia.
    Rossi S; Daniele I; Bastrenta P; Mastrangelo M; Lista G
    Pediatr Neurol; 2009 Nov; 41(5):371-4. PubMed ID: 19818941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poor outcome for neonatal-type nonketotic hyperglycinemia treated with high-dose sodium benzoate and dextromethorphan.
    Chien YH; Hsu CC; Huang A; Chou SP; Lu FL; Lee WT; Hwu WL
    J Child Neurol; 2004 Jan; 19(1):39-42. PubMed ID: 15032382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strychnine therapy in nonketotic hyperglycinemia.
    Arneson D; Ch'ien LT; Chance P; Wilroy RS
    Pediatrics; 1979 Mar; 63(3):369-73. PubMed ID: 440838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic trial of NMDA antagonist for a nonketotic hyperglycinemic infant].
    Imai M; Kitajima H; Tokoro T; Kubo M; Maekawa K
    No To Hattatsu; 1995 Jul; 27(4):327-9. PubMed ID: 7612297
    [No Abstract]   [Full Text] [Related]  

  • 14. Transient neonatal nonketotic hyperglycinemia: a 13-year follow-up.
    Zammarchi E; Donati MA; Ciani F
    Neuropediatrics; 1995 Dec; 26(6):328-30. PubMed ID: 8719751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attempts at use of strychnine sulfate in the treatment of nonketotic hyperglycinemia.
    MacDermot KD; Nelson W; Reichert CM; Schulman JD
    Pediatrics; 1980 Jan; 65(1):61-4. PubMed ID: 7355037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of benzoate in the management of seizures in nonketotic hyperglycinemia.
    Wolff JA; Kulovich S; Yu AL; Qiao CN; Nyhan WL
    Am J Dis Child; 1986 Jun; 140(6):596-602. PubMed ID: 3706242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonketotic hyperglycinemia. Glycine accumulation due to absence of glycerine cleavage in brain.
    Perry TL; Urquhart N; MacLean J; Evans ME; Hansen S; Davidson GF; Applegarth DA; MacLeod PJ; Lock JE
    N Engl J Med; 1975 Jun; 292(24):1269-73. PubMed ID: 1128590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neonatal form of a nonketotic hyperglycinemia in consanguinous parents].
    Plöchl E; Rittinger O; Doringer E; Laubichler W
    Klin Padiatr; 1991; 203(6):455-7. PubMed ID: 1758150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurodevelopmental Outcome and Treatment Efficacy of Benzoate and Dextromethorphan in Siblings with Attenuated Nonketotic Hyperglycinemia.
    Bjoraker KJ; Swanson MA; Coughlin CR; Christodoulou J; Tan ES; Fergeson M; Dyack S; Ahmad A; Friederich MW; Spector EB; Creadon-Swindell G; Hodge MA; Gaughan S; Burns C; Van Hove JL
    J Pediatr; 2016 Mar; 170():234-9. PubMed ID: 26749113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A patient with neonatal citrullinemia].
    Berghuis M; Cats BP; de Klerk JB; Duran M
    Tijdschr Kindergeneeskd; 1983 Jun; 51(3):104-9. PubMed ID: 6636107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.